Hua Medicine (Shanghai) Ltd. (HKG:2552)

Hua Medicine (Shanghai) Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,140	1,461	490.63	675.24	1,032
Cash & Short-Term Investments	1,140	1,461	490.63	675.24	1,032
Cash Growth	-21.98%	197.74%	-27.34%	-34.58%	-6.65%
Accounts Receivable	34.39	0.98	12.94	-	-
Other Receivables	22.18	15.81	408.96	9.7	9.23
Receivables	56.57	16.79	421.9	9.7	9.23
Inventory	126.7	67.87	18.46	-	-
Other Current Assets	13.48	27	9.27	19.66	3.96
Total Current Assets	1,336	1,572	940.26	704.6	1,045
Property, Plant & Equipment	129.66	114.54	139.71	156.6	123.52
Other Intangible Assets	26.07	28.57	31.95	9.03	3.39
Other Long-Term Assets	35.07	9.79	9.58	33.33	26.34
Total Assets	1,527	1,725	1,121	903.55	1,199
Accounts Payable	63.72	51.63	20.98	23.79	25.82
Accrued Expenses	37.9	37.17	38.37	32.15	32.29
Short-Term Debt	-	-	33.92	-	-
Current Portion of Long-Term Debt	98.28	17.19	-	-	-
Current Portion of Leases	17.26	24.28	21.49	13.3	11.5
Current Unearned Revenue	98.04	98.38	53.86	13.85	14.25
Other Current Liabilities	15.07	23.38	19.76	23.8	22.69
Total Current Liabilities	330.27	252.03	188.39	106.88	106.55
Long-Term Debt	138.74	106.84	-	-	-
Long-Term Leases	45.91	19.44	42.17	58.23	69.21
Long-Term Unearned Revenue	1,148	1,246	611.36	288.11	290.27
Total Liabilities	1,663	1,624	841.92	453.22	466.03
Common Stock	7.21	7.21	7.21	7.21	7.21
Additional Paid-In Capital	5,932	5,931	5,922	5,910	5,900
Retained Earnings	-6,361	-6,111	-5,900	-5,696	-5,370
Treasury Stock	-0.49	-0.51	-0.58	-0.63	-0.69
Comprehensive Income & Other	286.43	274.5	250.96	229.63	196.54
Total Common Equity	-135.47	101.15	279.58	450.33	732.5
Shareholders' Equity	-135.47	101.15	279.58	450.33	732.5
Total Liabilities & Equity	1,527	1,725	1,121	903.55	1,199
Total Debt	300.18	167.75	97.58	71.53	80.72
Net Cash (Debt)	839.57	1,293	393.05	603.71	951.38
Net Cash Growth	-35.07%	228.98%	-34.89%	-36.54%	-6.33%
Net Cash Per Share	0.86	1.32	0.41	0.63	1.00
Filing Date Shares Outstanding	983.66	980.52	970.11	963.55	953.98
Total Common Shares Outstanding	983.66	980.52	970.11	963.55	953.98
Working Capital	1,006	1,320	751.87	597.72	938.73
Book Value Per Share	-0.14	0.10	0.29	0.47	0.77
Tangible Book Value	-161.53	72.58	247.63	441.31	729.11
Tangible Book Value Per Share	-0.16	0.07	0.26	0.46	0.76
Machinery	27.33	25.49	23.46	21.61	20.24
Construction In Progress	24.54	22.4	21.3	18.92	0.85
Leasehold Improvements	44.15	43.88	43.33	40.06	39.26

Source: S&P Global Market Intelligence. Standard template. Financial Sources.